Alterations of peptide metabolism and neuropeptidase activity in senile dementia of the Alzheimer's type

Annals of the New York Academy of Sciences

Volumn 814, Issue , 1997, Pages 30-39

  Waters, Stephen M ^a,b   Davis, Thomas P ^a  

^a UNIVERSITY OF ARIZONA   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN ENZYME; CARBOXYPEPTIDASE; MEMBRANE METALLOENDOPEPTIDASE; METALLOPROTEINASE; NEUROPEPTIDASE; NEUROPEPTIDE; PEPTIDASE; SOMATOSTATIN; SUBSTANCE P; TRYPTASE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; AUTOPSY; BRAIN REGION; CAUDATE NUCLEUS; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE COURSE; DRUG HALF LIFE; ENZYME ACTIVITY; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PROTEIN DEGRADATION; PROTEIN METABOLISM; SENILE DEMENTIA; TEMPORAL CORTEX;

EID: 0030986237     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1997.tb46142.x     Document Type: Conference Paper

References (44)

1. PRICE, D. L., E. H. KOO & A. UNTERBACK. 1989. Cellular and molecular biology of Alzheimer's disease. Bioessays 10: 69-74.
2. TERRY, R. D. & P. DAVIES. 1980. Dementia of the Alzheimer's type. Annu. Rev. Neurosci. 3: 77-95.
3. DAVIES, P. 1979. Neurotransmitter related enzymes in senile dementia of the Alzheimer's type. Brain Res. 171: 319-327.
4. ROSSOR, M. N., N. J. GARRET, A. L. JOHNSON, C. Q. MOUNTJOY, M. ROTH & L. L. IVERSON. 1982. A post-mortem study of the cholinergic and GABA systems in senile dementia. Brain 105: 313-330.
5. PERRY, E. K. 1986. The cholinergic hypothesis: Ten years on. Br. Med. Bull. 42: 63-69.
6. FERRIER, I. N., A. J. CROSS, J. A. JOHNSON, B. W. ROBERTS, T. J. CROW, S. A. N. CORSELLIS, Y. C. LEE, D. O'SHAUGHNESSY, T. E. ADRIAN, G. P. MCGREGOR, A. J. BARACESE-HAMILTON & S. R. BLOOM. 1983. Neuropeptides in Alzheimer's type dementia. J. Neurol. Sci. 62: 159-170.
7. JOLKKONEN, J., P. HARTIKAINEN, R. SOIKKELI, G. BISSETTE, C. B. NEMEROFF & P. RIEKKINEN. 1991. A correlation study of CSF neuropeptides in Alzheimer's and Parkinson's disease. Neuropeptides 19: 97-102.
8. GABRIEL, S. M., L. M. BIERER, V. HAROTUNIAN, D. P. PUROHIT, D. P. PERL & K. L. DAVIS. 1993. Widespread deficits in somatostatin but not neuropeptide Y concentrations in Alzheimer's disease cerebral cortex. Neurosci. Lett. 155: 116-120.
9. CRYSTAL, H. A. & P. DAVIES. 1982. Cortical substance P-like immunoreactivity in cases of Alzheimer's disease and senile dementia of the Alzheimer's type. J. Neurochem. 38: 1781-1784.
10. QUIGLEY, B. J. & N. W. KOWALL. 1991. Substance P-like immunoreactive neurons are depleted in Alzheimer's disease cerebral cortex. Neuroscience 41: 41-60.
11. DAVIES, P., R. KATZMAN & R. D. TERRY. 1980. Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer's disease and Alzheimer's senile dementia. Nature 288: 279-280.
12. BEAL, M. F., R. BENOIT, M. F. MAZUREK, E. D. BIRD & J. B. MARTIN. 1986. Somatostatin-28 (1-12)-like immunoreactivity is reduced in Alzheimer's disease cerebral cortex. Brain Res. 368: 380-383.
13. HUSAIN, M. M. & C. B. NEMEROFF. 1990. Neuropeptides and Alzheimer's disease. J. Am. Geriatr. Soc. 38: 918-925.
14. YANKNER, B. A., L. K. DUFFY & D. A. KIRSCHNER. 1990. Neurotrophic and neurotoxic effects of amyloid β protein: Reversal by tachykinin neuropeptides. Science 250: 279-282.
15. KOWALL, N. W., M. F. BEAL, J. BUSCIGLIO, L. K. DUFFY & B. A. YANKNER. 1991. An in vivo model for the neurodegenerative effects of β amyloid and protection by substance P. Proc. Natl. Acad. Sci. USA 88: 7247-7251.
16. MCKELVY, J. F. & S. BLUMBERG. 1986. Inactivation and metabolism of neuropeptides. Annu. Rev. Neurosci. 9: 415-434.
17. KONKOY, C. S., S. M. WATERS & T. P. DAVIS. 1994. Acute administration of neuroleptics decreases neurotensin metabolism on intact, regional rat brain slices. J. Pharmacol. Exp. Ther. 269: 555-563.
18. WATERS, S. M., C. S. KONKOY & T. P. DAVIS. 1995. Neuropeptide metabolism on intact, regional brain slices: Effect of dopaminergic agents on substance P, cholecystokinin and met-enkephalin degradation. J. Pharmacol. Exp. Ther. 274: 783-789.
19. 5]enkephalin metabolism in rat striatum and cortex. Eur. J. Pharmacol. 297: 47-51.
20. WATERS, S. M., C. S. KONKOY & T. P. DAVIS. 1996. Haloperidol and apomorphine differentially affect neuropeptidase activity. J. Pharmacol. Exp. Ther. 277: 113-120.
21. WEBER, S. J., R. B. LOUIS, L. TROMBLEY, G. BISSETTE, P. DAVIES & T. P. DAVIS. 1992. Metabolic half-life of somatostatin and peptidase activities are altered in Alzheimer's disease. J. Gerontol. 47: B18-25.
22. WATERS, S. M. & T. P. DAVIS. 1995. Alterations of substance P metabolism and neuropeptidases in Alzheimer's disease. J. Gerontol. 50A: B315-B319.
23. SCHOEMAKER, H. & T. P. DAVIS. 1984. Differential in vitro metabolism of β-endorphin in schizophrenia. Peptides 5: 1049-1054.
24. DELFS, J., R. ROBBINS, J. L. CONNOLLY, M. DICHTER & S. REICHLIN. 1980. Somatostatin production by rat cerebral neurones in dissociated cell culture. Nature 283: 676-677.
25. LINDBERG, I., H.-Y.T. YANG & E. COSTA. 1984. Further characterization of an enkephalin-generating enzyme from adrenal medullary chromaffin granules. J. Neurochem. 42: 1411-1419.
26. VECSEI, L., I. BOLLOK & G. TELEGDY. 1984. Phenoxybenzamine antagonizes somatostatin-induced anti-amnesia in rats. Eur. J. Pharmacol. 99: 325-328.
27. SCHETTINI, G., T. FLORIO, G. MAORI, M. GRIMALDI, O. MENCCI, E. LANDOLFI & A. MANIRCO. 1988. Somatostatin and SMS 201-995 reverse the impairment of cognitive functions induced by cysteamine depletion of brain somatostatin. Eur. J. Pharmacol. 151: 399-407.
28. DAVIS, T. P., A. J. CULLING-BERGLUND, H. SCHOEMAKER. 1986. Specific regional differences of in vitro β-endorphin metabolism in schizophrenia. Life Sci. 39: 2601-2609.
29. ICHAI, C., N. CHEVALLIER, P. DELAERE, P. DOURNAUD, J. EPELBAUM, J.-J. HAUW, J.-P. VINCENT & F. CHECLER. 1994. Influence of region-specific alterations of neuropeptidase content on the catabolic fates of neuropeptides in Alzheimer's disease. J. Neurochem. 62: 645-655.
30. EMSON, P. C., A. ARREGUI, V. CLEMENT-JONES, B. E. B. SANDBERG & M. ROSSOR. 1980. Regional distribution of methionine-enkephalin and substance P-like immunoreactivity in normal human brain and in Huntington's disease. Brain Res. 199: 147-160.
31. COOPER, P. E., M. H. FERNSTROM, O. P. RORSTAD, S. E. LEEMAN & J. B. MARTIN. 1981. The regional distribution of somatostatin, substance P and neurotensin in human brain. Brain Res. 218: 219-232.
32. DAUCH, P., Y. MASUO, J.-P. VINCENT & F. CHECLER. 1993. A survey of the cerebral regionalization and ontogeny of eight exo- and endopeptidases in murines. Peptides 14: 593-599.
33. LEE, C.-M., B. E. B. SANDBERG, M. R. HANLEY & L. L. IVERSEN. 1981. Purification and characterization of a membrane-bound substance P-degrading enzyme from human brain. Eur. J. Biochem. 114: 315-327.
34. MENTLEIN, R. & P. DAHMS. 1994. Endopeptidases 24.16 and 24.15 are responsible for the degradation of somatostatin, neurotensin and other neuropeptides by cultivated rat cortical astrocytes. J. Neurochem. 62: 27-36.
35. THIELE, E. A., S. M. STRITTMATTER & S. H. SNYDER. 1985. Substance K and substance P as possible endogenous substrates of angiotensin converting enzyme in the brain. Biochem. Biophys. Res. Commun. 128: 317-324.
36. WANG, L., S. AHMAD, I. F. BENTER, A. CHOW, S. MIZUTANI & P. WARD. 1991. Differential processing of substance P and neurokinin A by plasma dipeptidyl(amino)-peptidase IV, aminopeptidase M and angiotensin converting enzyme. Peptides 12: 1357-1364.
37. ALMENOFF, J., S. WILK & M. ORLOWSKI. 1981. Membrane bound pituitary metalloendopeptidase: Apparent identity to enkephalinase. Biochem. Biophys. Res. Commun. 102: 206-214.
38. 8. J. Neurochem. 48: 284-292.
39. CHECLER, F. 1993. Neuropeptide-degrading peptidases. In Methods in Neurotransmitter and Neuropeptide Research. S. H. Parvez, M. Naoi, T. Nagatsu & S. Parvez, Eds.: 375-418. Elsevier Science Publishers. New York.
40. BATEMAN, R. C. & L. B. HERSH. 1987. Evidence for an essential histidine in neutral endopeptidase 24.11. Biochemistry 26: 4237-4242.
41. ORLOWSKI, M., C. MICHAUD & T. G. CHU. 1983. A soluble metalloendopeptidase from rat brain. Eur. J. Biochem. 135: 81-88.
42. STACK, G., L. D. FRICKER & S. H. SNYDER. 1984. A sensitive radiometric assay for enkephalin convertase and other carboxypeptidase B-like enzymes. Life Sci. 34: 113-121.
43. ARREGUI, A., E. K. PERRY, M. ROSSOR, B. E. TOMLINSON. 1982. Angiotensin converting enzyme in Alzheimer's disease: Increased activity in caudate nucleus and cortical areas. J. Neurochem. 38: 1490-1492.
44. GRAY, E. G. & V. P. WHITTAKER. 1962. Isolation of nerve endings from brain: An electron microscopic study of cell fragments derived by homogenization and centrifugation. J. Anat. 96: 79-87.